# Nanodropper

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanodropper

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.nanodropper.com
- Total disclosed funding: $1.4M
- Latest round: Seed (Apr 19, 2021)
- Investors on record: 4

## About

Nanodropper, Inc., based in Rochester, NY, specializes in optimizing prescription eye medication delivery through its innovative product, the Nanodropper, which significantly reduces medication wastage.Founded in 2018, Nanodropper, Inc. creates devices that enhance the administration of eye medications. The company has raised USD 1.4 mn in its Seed funding round as of April 19, 2021, from investors including Alliance of Angels, Austin Area Angels, and others. The co-founders, Allisa Song and Jennifer Steger, have guided the company through its initial growth stages without notable pivots or changes in business strategy.Nanodropper specializes in a unique product designed to optimize the delivery of prescription eye medications. Their core offering is the Nanodropper, an FDA-listed volume-reducing adaptor that attaches to standard eyedrop bottles, effectively decreasing the drop size by over 60%. This innovation addresses a significant issue faced by patients: the excessive wastage of medication due to traditional eyedrop bottles, which dispense five times the liquid the eye can absorb, resulting in up to 80% of each drop being wasted. By providing smaller, more effective drops that remain in the eye, the Nanodropper aims to enhance patient compliance, reduce side effects, and ultimately lower the cost of eye care. The company targets a wide range of customers, including individuals suffering from glaucoma and other ocular conditions, as well as veterinary patients. Their products are distributed primarily in the United States, with plans to expand into additional international markets.Nanodropper generates revenue through direct sales of its flagship product, the Nanodropper adaptor, which is marketed to both healthcare professionals and end consumers. The company's transaction structure is primarily B2C, selling directly to patients via their website, while also establishing partnerships with healthcare providers and clinics. Customers can purchase the adaptor in two sizes that fit most eyecare bottles, enhancing accessibility and usability. Pricing information for the Nanodropper and associated products has not been disclosed, but the company's strategy focuses on providing cost-effective solutions to eye medication management, thereby appealing to individuals on fixed incomes and those looking to minimize healthcare expenses. The direct-to-consumer model combined with professional endorsements aims to drive customer adoption and increase sales volume over time.Nanodropper plans to utilize the recent Seed funding of USD 1.4 mn to enhance product development and expand its market presence. The company is focusing on the design and launch of additional products that improve medication administration, aiming for rollouts in the coming years. Additionally, Nanodropper targets expansion into international markets to broaden its reach and customer base. The specific regions and timelines for these expansions have not been disclosed, but the company is committed to improving access to its innovative solutions globally.

## Funding rounds

- Seed, Apr 19, 2021, $1.4M — Alliance of Angels, Golden Seeds, Rochester Area Economic Development, Inc, Austin Area Angels

## Investors

- Alliance of Angels (https://capitalatlas.ai/funds/alliance-of-angels) — Seed
- Golden Seeds (https://capitalatlas.ai/funds/golden-seeds) — Seed
- Rochester Area Economic Development, Inc — Seed
- Austin Area Angels (https://capitalatlas.ai/funds/austin-area-angels) — Seed